Related Experiment Video
Updated: Mar 13, 2026
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Spotlight on the relevance of mtDNA in cancer
A Cruz-Bermúdez1,2,3, R J Vicente-Blanco1,2, E Gonzalez-Vioque4
1Departamento de Bioquímica and Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Facultad de Medicina, UAM, Madrid, Spain.
Abstract:
The potential role of the mitochondrial genome has recently attracted interest because of its high mutation frequency in tumors. Different aspects of mtDNA make it relevant for cancer's biology, such as it encodes a limited but essential number of genes for OXPHOS biogenesis, it is particularly susceptible to mutations, and its copy number can vary. Moreover, most ROS in mitochondria are produced by the electron transport chain. These characteristics place the mtDNA in the center of multiple signaling pathways, known as mitochondrial retrograde signaling, which modifies numerous key processes in cancer. Cybrid studies support that mtDNA mutations are relevant and exert their effect through a modification of OXPHOS function and ROS production. However, there is still much controversy regarding the clinical relevance of mtDNA mutations. New studies should focus more on OXPHOS dysfunction associated with a specific mutational signature rather than the presence of mutations in the mtDNA.
Insights
Mitochondrial DNA mutations are linked to cancer through altered energy production and reactive oxygen species. Future research should examine specific mitochondrial DNA mutation patterns and their impact on OXPHOS dysfunction.
Area of Science:
- Mitochondrial biology
- Cancer research
- Genetics
Background:
- Mitochondrial DNA (mtDNA) mutations are frequent in tumors.
- mtDNA encodes essential oxidative phosphorylation (OXPHOS) genes and is susceptible to mutations.
- Mitochondrial retrograde signaling pathways are influenced by mtDNA, impacting cancer processes.
Purpose of the Study:
- To explore the role of mitochondrial DNA mutations in cancer biology.
- To investigate the link between mtDNA mutations, OXPHOS function, and reactive oxygen species (ROS) production.
- To address the controversy surrounding the clinical relevance of mtDNA mutations.
Main Methods:
- Analysis of mitochondrial genome mutation frequency in tumors.
- Cybrid studies to assess the functional impact of mtDNA mutations.
- Investigation of OXPHOS dysfunction and ROS production in relation to mtDNA mutations.
Main Results:
- mtDNA mutations can alter OXPHOS function and ROS production.
- Cybrid studies suggest a functional role for mtDNA mutations in cancer.
- Significant controversy remains regarding the clinical significance of mtDNA mutations.
Conclusions:
- mtDNA mutations play a role in cancer through OXPHOS and ROS pathways.
- Focusing on specific mutational signatures and OXPHOS dysfunction is crucial.
- Further research is needed to clarify the clinical relevance of mtDNA mutations in cancer.
Related Concept Videos
02:59Animal Mitochondrial Genetics
01:37Mitochondria
01:45Mitochondrial Membranes
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:19Export of Mitochondrial and Chloroplast Genes
01:19Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...